What is CancerSpot?
The blood test, CancerSpot, that looks for cancer-related changes in DNA has shown the potential to detect multiple types of cancer.

About CancerSpot:
- It is a blood test that looks for cancer-related changes in DNA.
- It was developed by Bengaluru-based Strand Life Sciences.
- How Does the Test Work?
- Cells in the body release small fragments of DNA into the bloodstream. These are known as circulating or cell-free DNA.
- In people with cancer, some of these fragments originate from tumour cells and carry changes that can help identify the disease.
- CancerSpot combines DNA sequencing with AI-based analysis to examine patterns of DNA methylation.
- Methylation refers to chemical modifications of DNA that influence how genes function.
- These patterns differ between cancer cells and normal cells and can be used to identify cancer-associated signals in a blood sample.
- By analysing these patterns, the test aims to detect multiple types of cancer through a single blood test, without requiring a tissue biopsy for the initial detection.
- Recent Study:
- It examined how DNA released by different cells in the body influences the detection of cancer.
- An important finding was that higher levels of circulating DNA were associated with stronger cancer-related signals and better detection sensitivity, even among patients at the same stage of cancer.
- Researchers had expected that the increased release of DNA from immune cells in cancer patients would dilute the tumour-derived DNA signals, making cancer detection more difficult. However, the study found the opposite.
- The findings suggest that DNA released by tumour cells and immune cells increases together in cancer patients, helping strengthen the cancer-related signals in the blood.
- This provides new insights into the interaction between tumours and the immune system and its role in blood-based cancer detection.
Source: Pan-Indian study finds that higher levels of DNA fragments in blood strengthen cancer signals